$Gilead Sciences (GILD.US)$ Raised to Outperform From Market Perform by BMO Capital
BMO Capital Upgrades Gilead Sciences to Outperform From Market Perform, Adjusts Price Target to $100 From $90.
$Cullen/Frost Bankers (CFR.US)$ Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley
Cullen/Frost Bankers Price Target Cut to $121.00/Share From $127.00 by Morgan Stanley.
$GE HealthCare Technologies (GEHC.US)$ Initiated at Outperfo...

$Palantir (PLTR.US)$
Palantir Q1 2023 earnings conference call is scheduled on MAY 8 at 5:00 PM ET / MAY 9 at 5:00 AM SGT. Subscribe to join the live earnings conference with the management NOW!
Previous Revenue and Net Income
Under the previous Income Statement in 2022/Q4:
Palantir's revenue was $508.62 million,up 17.50%
The net income of Palantir was $33.49 million, up 121.44% YOY.
Earnings Preview
Under the Financial Estimates for Q1:
Revenue: 11 analysts have made an average estimate of $505...